Dynamic Technology Lab’s Altimmune ALT Stock Holding History

Dynamic Technology Lab’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-30,260	Closed	-$78K	–	1009
2023 Q3	$78K	Buy	30,260 +15,704	+108%	+$45.1K	0.01%	873
2023 Q2	$51K	Sell	14,556 -27,801	-66%	-$125K	0.01%	929
2023 Q1	$179K	Buy	+42,357	New	+$503K	0.02%	926
2022 Q2	–	Sell	-17,355	Closed	-$106K	–	1090
2022 Q1	$106K	Buy	+17,355	New	+$128K	0.01%	1006

Other funds holding ALT

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TIM

Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return

Dynamic Technology Lab's ALT Position: Q4 2023 in Review

Dynamic Technology Lab sold out of Altimmune (ALT) in Q4 2023, closing a stake of 30,260 shares — an estimated $78K sold.

Dynamic Technology Lab first reported a position in ALT in Q1 2022 and held it in 4 quarters. The position peaked at $179K in Q1 2023. 143 funds tracked by Wall St. Rank hold ALT as of Q4 2023.

Dynamic Technology Lab reported no remaining Altimmune position as of Q4 2023 after selling out during the quarter.
Dynamic Technology Lab sold 30,260 Altimmune shares in Q4 2023, an estimated $78K.
Dynamic Technology Lab first reported a position in Altimmune in Q1 2022 and held it in 4 quarters.
Dynamic Technology Lab's Altimmune position peaked at $179K in Q1 2023.
143 funds tracked by Wall St. Rank held Altimmune as of Q4 2023.

Based on Dynamic Technology Lab's 13F filing for Q4 2023, filed 9 Feb 2024.